Accelerator
Finance · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2815 Eastlake Ave E Ste 300, Seattle, Wa...Phone Number
(206) 957-7300Website
www.acceleratorlsp.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
2
2
1
About Accelerator
Accelerator Life Science Partners catalyzes the development and commercialization of breakthrough biotechnology innovations. The company is trusted partners that provide a complete business, scientific, and financial toolkit necessary for successfully establishing and operating an early-stage biotechnology company. The company nurture the company's companies across all stages and in all facets of development, setting them on a path that offers the greatest chance for long-term success. Among these key resources are committed investment capital, experienced start-up management, world-class scientific expertise, and state-of-the-art laboratories and shared facilities. The company is uniquely positioned to provide this unprecedented collection of capabilities and resources through the company's partnership with top-tier investors, seasoned executive managers, and numerous world-class research institutions that partner closely with the company. The company's partners have extensive experieRead more
Accelerator Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Accelerator your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Accelerator, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Accelerator recently announced quarterly report
Check out if Accelerator is spiking on competitors!
Funding: Get notified immidiatlly once Accelerator has new funding data
Congratulate Masked Content for being promoted to Masked Content at Accelerator
Check if Accelerator has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Accelerator had a recent Job posting/layoffs
Product Launch: Get notified when Accelerator launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Accelerator
Compare insights from companies similar to Accelerator, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Accelerator is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Accelerator is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Accelerator.
Accelerator financials insights
Gather financial insights about Accelerator, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2003
Other Financing Round
$15M
2004
Other Financing Round
$11.8M
2007
Series C
$22.5M
Accelerator Tech Stack
A closer look at the technologies used by Accelerator
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Initial Public Offering (IPO)
Initial Public Offering (IPO)
Initial Public Offering (IPO)
Accelerator News & Media
KayoThera, Inc. Nominates First-in-Class, Oral Inhibitor of the Retinoid Pathway in Genetically Defined Oncology Indications as a Development Candidate
SEATTLE--(BUSINESS WIRE)--KayoThera, Inc. (“KayoThera”), an early-stage therapeutics company developing first-in-class, oral, small molecule inhibitors of the retinoid pathway, today announces that it has selected KAYO-1609 as its first drug development candidate. KAYO-1609 has demonstrated a differentiated safety profile across a variety of species with ideal drug-like properties. Preclinical studies in multiple models of cancer support the potential of KAYO-1609 in the treatment of geneticallKayoThera, Inc. Strengthens Financial Position with $5.2 Million in Grant and Expanded ...
KayoThera, Inc. (“KayoThera”), an early-stage therapeutics company developing first-in-class, oral, small molecule inhibitors of the retinoid pathway,KayoThera, Inc. Strengthens Financial Position with $5.2 Million in Grant and Expanded Series A Funding, Bringing Total Financial Support to $14 Million
SEATTLE--(BUSINESS WIRE)--KayoThera, Inc. (“KayoThera”), an early-stage therapeutics company developing first-in-class, oral, small molecule inhibitors of the retinoid pathway, today announces the strengthening of its financial resources through multiple grant awards and expansion of its previously announced Series A financing. The expanded financing was led by Accelerator Life Science Partners (ALSP), who also provided Series A funding for KayoThera. With the additional $5.2 million in new equCountry Engagement Coordinator (Resilient Water Accelerator)
Countries: Mozambique, Rwanda, United Kingdom of Great Britain and Northern Ireland Organization: WaterAid Closing date: 8 Jun 2022 Want to use your skills in managing in-country programmes and leading government engagement efforts to play a vital role in building the climate resilience of 50 million vulnerable people? Join the Resilient Water Accelerator (hosted by WaterAid) as the Resilient Water Accelerator's Country Engagement Coordinator. By joining Water Aid, you'll also be joining a 2020
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Accelerator
Sign Up For FreeTo access detailed company insights
Accelerator Life Science Partners catalyzes the development and commercialization of breakthrough biotechnology innovations. The company is trusted partners that provide a complete business, scientific, and financial toolkit necessary for successfully establishing and operating an early-stage biotechnology company. The company nurture the company's... Read More
